Literature DB >> 19696176

Functional role of proteolytic processing of recombinant myocilin in self-aggregation.

José-Daniel Aroca-Aguilar1, Francisco Martínez-Redondo, Francisco Sánchez-Sánchez, Miguel Coca-Prados, Julio Escribano.   

Abstract

PURPOSE: Recombinant myocilin expressed in cells in culture is endoproteolytically cleaved in the endoplasmic reticulum by calpain II, releasing an N-terminal and a C-terminal fragment. This proteolytic processing has been speculated to regulate the molecular interactions of myocilin. The main purpose of this study was to analyze the effect of the proteolytic cleavage on myocilin aggregation.
METHODS: cDNAs encoding human myocilin and the N- and C-terminal fragments were transiently expressed in HEK-293T cells. Covalent interactions of recombinant myocilin were analyzed by SDS-PAGE and Western immunoblot analysis in different dissociating conditions. Noncovalent interactions were studied by solid-phase binding assays, performed with Ni-chelating HPLC-purified recombinant proteins, and by Far-Western blot analysis.
RESULTS: Western blot analysis of recombinant myocilin aggregates under either increasing ionic strength or increasing concentration of reducing agent indicated that ionic interactions do not contribute to the stability of the molecular complexes linked by disulfide bridges. Disulfide myocilin homoaggregates decreased as the proteolytic processing increased. Solid-phase binding assays showed the existence of high-affinity (K(d) = 0.068 microM) noncovalent myocilin-myocilin interactions and that processed fragments bound to the full-length protein with significantly reduced affinity. Far-Western blot analysis confirmed noncovalent interactions between recombinant myocilin disulfide aggregates.
CONCLUSIONS: The proteolytic processing of recombinant myocilin decreases myocilin homoaggregates. These data provide the first evidence of a functional role for this processing in myocilin aggregation and suggest that disulfide complexes of myocilin could organize into a dynamic extracellular network sustained by noncovalent N-terminal interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696176      PMCID: PMC2869055          DOI: 10.1167/iovs.09-4118

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

1.  The secreted glycoprotein Noelin-1 promotes neurogenesis in Xenopus.

Authors:  T A Moreno; M Bronner-Fraser
Journal:  Dev Biol       Date:  2001-12-15       Impact factor: 3.582

2.  Expression and characterization of the olfactomedin domain of human myocilin.

Authors:  Ildikó Nagy; Mária Trexler; László Patthy
Journal:  Biochem Biophys Res Commun       Date:  2003-03-14       Impact factor: 3.575

3.  The presence and properties of myocilin in the aqueous humor.

Authors:  P Russell; E R Tamm; F J Grehn; G Picht; M Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-04       Impact factor: 4.799

Review 4.  Studying protein-protein interactions via blot overlay or Far Western blot.

Authors:  Randy A Hall
Journal:  Methods Mol Biol       Date:  2004

5.  Characterization of monoclonal antibodies against the glaucoma-associated protein myocilin.

Authors:  Mohamed-Karim Ezzat; Kyle G Howell; Cindy K Bahler; Thomas G Beito; Nils Loewen; Eric M Poeschla; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2008-07-12       Impact factor: 3.467

6.  Characterization of myocilin-myocilin interactions.

Authors:  M P Fautsch; D H Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-09       Impact factor: 4.799

7.  Localization of myocilin/trabecular meshwork--inducible glucocorticoid response protein in the human eye.

Authors:  A Karali; P Russell; F H Stefani; E R Tamm
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-03       Impact factor: 4.799

8.  In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin.

Authors:  Mark S Filla; Xuyang Liu; Thai D Nguyen; Jon R Polansky; Curtis R Brandt; Paul L Kaufman; Donna M Peters
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

9.  Did myocilin evolve from two different primordial proteins?

Authors:  Arijit Mukhopadhyay; Arnab Gupta; Saibal Mukherjee; Keya Chaudhuri; Kunal Ray
Journal:  Mol Vis       Date:  2002-07-22       Impact factor: 2.367

10.  Evaluation and understanding of myocilin mutations in Indian primary open angle glaucoma patients.

Authors:  Janakaraj Kanagavalli; Subbaiah Ramasamy Krishnadas; Eswari Pandaranayaka; Sankaran Krishnaswamy; Periasamy Sundaresan
Journal:  Mol Vis       Date:  2003-11-14       Impact factor: 2.367

View more
  14 in total

1.  Interaction of recombinant myocilin with the matricellular protein SPARC: functional implications.

Authors:  José-Daniel Aroca-Aguilar; Francisco Sánchez-Sánchez; Sikha Ghosh; Ana Fernández-Navarro; Miguel Coca-Prados; Julio Escribano
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

Review 2.  The effects of myocilin expression on functionally relevant trabecular meshwork genes: a mini-review.

Authors:  Teresa Borrás
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-24       Impact factor: 2.671

Review 3.  Common and rare genetic risk factors for glaucoma.

Authors:  Ryan Wang; Janey L Wiggs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-18       Impact factor: 6.915

Review 4.  Glaucoma: genes, phenotypes, and new directions for therapy.

Authors:  Bao Jian Fan; Janey L Wiggs
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

5.  Molecular architecture and modifications of full-length myocilin.

Authors:  Mackenzie D Martin; Dustin J E Huard; Ricardo C Guerrero-Ferreira; Ishani M Desai; Brett M Barlow; Raquel L Lieberman
Journal:  Exp Eye Res       Date:  2021-08-13       Impact factor: 3.770

6.  Cystatin a, a potential common link for mutant myocilin causative glaucoma.

Authors:  K David Kennedy; S A AnithaChristy; Lakisha K Buie; Teresa Borrás
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

Review 7.  Keeping an eye on myocilin: a complex molecule associated with primary open-angle glaucoma susceptibility.

Authors:  Farid Menaa; Carolina Ayumi Braghini; Jose Paulo Cabral De Vasconcellos; Bouzid Menaa; Vital Paulino Costa; Eugênio Santana De Figueiredo; Monica Barbosa De Melo
Journal:  Molecules       Date:  2011-06-27       Impact factor: 4.411

8.  Identification of myocilin as a blood plasma protein and analysis of its role in leukocyte adhesion to endothelial cell monolayers.

Authors:  José-Daniel Aroca-Aguilar; Ana Fernández-Navarro; Jesús Ontañón; Miguel Coca-Prados; Julio Escribano
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

9.  Bicarbonate-dependent secretion and proteolytic processing of recombinant myocilin.

Authors:  José-Daniel Aroca-Aguilar; Francisco Martínez-Redondo; Alba Martín-Gil; Jesús Pintor; Miguel Coca-Prados; Julio Escribano
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

Review 10.  The Genetic and Endoplasmic Reticulum-Mediated Molecular Mechanisms of Primary Open-Angle Glaucoma.

Authors:  Wioletta Rozpędek-Kamińska; Radosław Wojtczak; Jacek P Szaflik; Jerzy Szaflik; Ireneusz Majsterek
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.